ArticleFrontiers in oncology2022

Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study.

Moaath K Mustafa Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.